Viatris (VTRS) Cash & Equivalents (2018 - 2026)

Viatris (VTRS) recorded quarterly Cash & Equivalents of $1.8 billion in Q1 2026, up 36.43% quarter-over-quarter from $1.3 billion in Q4 2025, and up 138.97% on a YoY basis from $755.0 million in Q1 2025.

Viatris (VTRS) Cash & Equivalents (2018 - 2026) Analysis & Trends

Viatris' Cash & Equivalents history runs 9 years deep, the most recent figure standing at $1.8 billion for Q1 2026.

  • In Q1 2026, Cash & Equivalents rose 138.97% year-over-year to $1.8 billion; the TTM figure through Mar 2026 stood at $1.8 billion (up 138.97% YoY), while the FY2025 annual figure was $1.3 billion, up 79.65% from the prior year.
  • Cash & Equivalents was $1.8 billion for Q1 2026 at Viatris, up from $1.3 billion in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.9 billion in Q3 2024 to a low of $506.6 million in Q1 2023.
  • Historically, Cash & Equivalents has averaged $984.3 million across 5 years, with a median of $917.2 million in 2024.
  • The sharpest annual moves came in 2025 and 2026: Cash & Equivalents slumped 48.09% in 2025, then surged 138.97% in 2026.
  • A 5-year view of Cash & Equivalents shows it stood at $1.3 billion in 2022, then declined by 21.43% to $991.9 million in 2023, then retreated by 25.79% to $736.1 million in 2024, then jumped by 79.65% to $1.3 billion in 2025, then soared by 36.43% to $1.8 billion in 2026.
  • The last three Cash & Equivalents figures came in at $1.8 billion (Q1 2026), $1.3 billion (Q4 2025), and $975.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 3.74 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 1.94 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 1.28 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 40.42 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 266.50 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 428.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 351.55 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 222.27 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 498.58 Mn
10 Viatris - - 1.16 Bn 1.80 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.80 Bn
Dec 31, 2025 1.32 Bn
Sep 30, 2025 975.30 Mn
Jun 30, 2025 566.40 Mn
Mar 31, 2025 755.00 Mn
Dec 31, 2024 736.10 Mn
Sep 30, 2024 1.88 Bn
Jun 30, 2024 917.20 Mn
Mar 31, 2024 1.01 Bn
Dec 31, 2023 991.90 Mn
Sep 30, 2023 1.31 Bn
Jun 30, 2023 629.20 Mn
Mar 31, 2023 506.60 Mn
Dec 31, 2022 1.26 Bn
Sep 30, 2022 646.70 Mn
Jun 30, 2022 664.70 Mn
Mar 31, 2022 752.40 Mn
Dec 31, 2021 706.20 Mn
Sep 30, 2021 756.60 Mn
Jun 30, 2021 673.90 Mn